Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshio Sumida

Showing results (211-220 of 220) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 220 results.
Journal of Gastroenterology|March 18, 2025
Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosisTsubasa Tsutsumi, Takumi Kawaguchi, Hideki Fujii, et al.
Journal of Gastroenterology and Hepatology|October 5, 2022
Age-dependent effects of diabetes and obesity on liver-related events in non-alcoholic fatty liver disease: Subanalysis of CLIONE in AsiaYuya Seko, Miwa Kawanaka, Hideki Fujii, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 27, 2023
Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver diseaseHideki Fujii, Makoto Fujii, Michihiro Iwaki, et al.
Journal of Gastroenterology|October 13, 2015
Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter surveyKatsutoshi Tokushige, Hideyuki Hyogo, Tomoaki Nakajima, et al.
Journal of Gastroenterology and Hepatology|August 19, 2023
Identification of clinical phenotypes associated with poor prognosis in patients with nonalcoholic fatty liver disease via unsupervised machine learningTakanori Ito, Hikaru Morooka, Hirokazu Takahashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 25, 2024
Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver diseaseKazuhiro Nouso, Miwa Kawanaka, Hideki Fujii, et al.
International Journal of Molecular Sciences|July 17, 2020
Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?Yoshio Sumida, Masashi Yoneda, Hidenori Toyoda, et al.
Nutrients|July 11, 2023
Association of Serum Albumin Levels and Long-Term Prognosis in Patients with Biopsy-Confirmed Nonalcoholic Fatty Liver DiseaseHirokazu Takahashi, Miwa Kawanaka, Hideki Fujii, et al.
Diagnostics (Basel, Switzerland)|July 12, 2025
Tips for Hepatologist Referral of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease with Alanine Aminotransferase Levels ≤ 30 U/LMiwa Kawanaka, Hideki Fujii, Michihiro Iwaki, et al.
Gut|May 18, 2021
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysisFerenc Emil Mózes, Jenny A Lee, Emmanuel Anandraj Selvaraj, et al.
Pageof 22

Showing results (211-220 of 220) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 220 results.
Journal of Gastroenterology|March 18, 2025
Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosisTsubasa Tsutsumi, Takumi Kawaguchi, Hideki Fujii, et al.
Journal of Gastroenterology and Hepatology|October 5, 2022
Age-dependent effects of diabetes and obesity on liver-related events in non-alcoholic fatty liver disease: Subanalysis of CLIONE in AsiaYuya Seko, Miwa Kawanaka, Hideki Fujii, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 27, 2023
Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver diseaseHideki Fujii, Makoto Fujii, Michihiro Iwaki, et al.
Journal of Gastroenterology|October 13, 2015
Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter surveyKatsutoshi Tokushige, Hideyuki Hyogo, Tomoaki Nakajima, et al.
Journal of Gastroenterology and Hepatology|August 19, 2023
Identification of clinical phenotypes associated with poor prognosis in patients with nonalcoholic fatty liver disease via unsupervised machine learningTakanori Ito, Hikaru Morooka, Hirokazu Takahashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 25, 2024
Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver diseaseKazuhiro Nouso, Miwa Kawanaka, Hideki Fujii, et al.
International Journal of Molecular Sciences|July 17, 2020
Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?Yoshio Sumida, Masashi Yoneda, Hidenori Toyoda, et al.
Nutrients|July 11, 2023
Association of Serum Albumin Levels and Long-Term Prognosis in Patients with Biopsy-Confirmed Nonalcoholic Fatty Liver DiseaseHirokazu Takahashi, Miwa Kawanaka, Hideki Fujii, et al.
Diagnostics (Basel, Switzerland)|July 12, 2025
Tips for Hepatologist Referral of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease with Alanine Aminotransferase Levels ≤ 30 U/LMiwa Kawanaka, Hideki Fujii, Michihiro Iwaki, et al.
Gut|May 18, 2021
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysisFerenc Emil Mózes, Jenny A Lee, Emmanuel Anandraj Selvaraj, et al.
Pageof 22